High PAR1 expression was found in tumors including malignant melanoma [15] and breast cancer [16], [17] and correlated with invasiveness and motility of numerous cancer cell lines [18], [19], [20], [21], indicating that PAR1 might act as an oncogene. This evidence concerns the gene F2R and breast cancer.